Penn-Nicholson, A., Tameris, M., Smit, E., Day, T. A., Musvosvi, M., Jayashankar, L., Vergara, J., Mabwe, S., Bilek, N., Geldenhuys, H., Luabeya, A. K., Ellis, R., Ginsberg, A. M., Hanekom, W. A., Reed, S. G., Coler, R. N., Scriba, T. J., Hatherill, M., & , (2018). safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Lancet, 6(4), 287–298. http://access.bl.uk/ark:/81055/vdc_100059393628.0x00000c